9 results on '"Morbelli, SILVIA DANIELA"'
Search Results
2. Hybrid Imaging in Pediatric Central Nervous System Disorders
- Author
-
Morana, Giovanni, Morbelli, Silvia Daniela, Piccardo, Arnoldo, Rossi, Andrea, Ciarmiello, Andrea, Ciarmiello, Andrea, editor, and Mansi, Luigi, editor
- Published
- 2016
- Full Text
- View/download PDF
3. Mycoplasma hominisas Cause of Extragenital Infection in Patients with Hypogammaglobulinemia: Report of 2 Cases and Literature Review
- Author
-
Russo, Chiara, Mikulska, Malgorzata, Delfino, Emanuele, Toscanini, Federica, Mezzogori, Laura, Schiavoni, Riccardo, Bartalucci, Claudia, Angelucci, Emanuele, Bartalucci, Giulia, Gambella, Massimiliano, Raiola, Anna Maria, Morici, Paola, Crea, Francesca, Chiola, Silvia, Morbelli, Silvia Daniela, Marchese, Anna, and Bassetti, Matteo
- Abstract
Mycoplasma hominiscan be a part of human urogenital tract microbiome, and it is a frequent cause of urogenital infections. In rare cases, it can also cause extragenital infections, especially in immunocompromised patients. In this case series, we report two cases and provide a literature review of extragenital infections caused by M. hominisin patients with hypogammaglobulinemia. Patient 1 was a 61-year-old woman with diffuse large B-cell lymphoma who, after rituximab-containing chemotherapy and CAR-T therapy, developed M. hominisspondylodiscitis. Patient 2 was a 50-year-old woman with congenital hypogammaglobulinemia who developed disseminated M. hominisinfection involving pleura, muscles, and right ankle. Antibiotic therapy with levofloxacin and doxycycline for 10 weeks in patient 1 and with levofloxacin alone for 6 weeks in patient 2 led to infection resolution. The literature review identified 14 additional cases reporting M. hominisextragenital infection in patients with hypogammaglobulinemia. M. hominisshould also be suspected as an etiological agent of extragenital infection in patients with B-cell immunodeficiency with a clinical picture of persistent, standard-culture negative infection, particularly with arthritis or abscess formation. Even if M. hominiscan grow on standard bacterial medium, in suspected cases molecular methods should be promptly used for correct diagnostic work-up and successful therapy.
- Published
- 2024
- Full Text
- View/download PDF
4. Non-conventional and Investigational PET Radiotracers for Breast Cancer: A Systematic Review
- Author
-
Balma, Michele, primary, Liberini, Virginia, additional, Racca, Manuela, additional, Laudicella, Riccardo, additional, Bauckneht, Matteo, additional, Buschiazzo, Ambra, additional, Nicolotti, Daniele Giovanni, additional, Peano, Simona, additional, Bianchi, Andrea, additional, Albano, Giovanni, additional, Quartuccio, Natale, additional, Abgral, Ronan, additional, Morbelli, Silvia Daniela, additional, D'Alessandria, Calogero, additional, Terreno, Enzo, additional, Huellner, Martin William, additional, Papaleo, Alberto, additional, and Deandreis, Désirée, additional
- Published
- 2022
- Full Text
- View/download PDF
5. Prevalence Estimates of Amyloid Abnormality Across the Alzheimer Disease Clinical Spectrum
- Author
-
Jansen, Willemijn J, Janssen, Olin, von Arnim, Christine, Marquié, Marta, Martinez-Lage, Pablo, Maserejian, Nancy, Mattsson, Niklas, de Mendonça, Alexandre, Meyer, Philipp T, Miller, Bruce L, Minatani, Shinobu, Mintun, Mark A, Mok, Vincent C T, Baiardi, Simone, Molinuevo, Jose Luis, Morbelli, Silvia Daniela, Morris, John C, Mroczko, Barbara, Na, Duk L, Newberg, Andrew, Nobili, Flavio, Nordberg, Agneta, Olde Rikkert, Marcel G M, de Oliveira, Catarina Resende, Baldeiras, Ines, Olivieri, Pauline, Orellana, Adela, Paraskevas, George, Parchi, Piero, Pardini, Matteo, Parnetti, Lucilla, Peters, Oliver, Poirier, Judes, Popp, Julius, Prabhakar, Sudesh, Barthel, Henryk, Rabinovici, Gil D, Ramakers, Inez H, Rami, Lorena, Reiman, Eric M, Rinne, Juha O, Rodrigue, Karen M, Rodríguez-Rodriguez, Eloy, Roe, Catherine M, Rosa-Neto, Pedro, Rosen, Howard J, Bateman, Randall J, Rot, Uros, Rowe, Christopher C, Rüther, Eckart, Ruiz, Agustín, Sabri, Osama, Sakhardande, Jayant, Sánchez-Juan, Pascual, Sando, Sigrid Botne, Santana, Isabel, Sarazin, Marie, Van Berckel, Bart, Scheltens, Philip, Schröder, Johannes, Selnes, Per, Seo, Sang Won, Silva, Dina, Skoog, Ingmar, Snyder, Peter J, Soininen, Hilkka, Sollberger, Marc, Sperling, Reisa A, Binette, Alexa Pichet, Spiru, Luisa, Stern, Yaakov, Stomrud, Erik, Takeda, Akitoshi, Teichmann, Marc, Teunissen, Charlotte E, Thompson, Louisa I, Tomassen, Jori, Tsolaki, Magda, Vandenberghe, Rik, Blennow, Kaj, Verbeek, Marcel M, Verhey, Frans R J, Villemagne, Victor, Villeneuve, Sylvia, Vogelgsang, Jonathan, Waldemar, Gunhild, Wallin, Anders, Wallin, Åsa K, Wiltfang, Jens, Wolk, David A, Boada, Merce, Yen, Tzu-Chen, Zboch, Marzena, Zetterberg, Henrik, Boecker, Henning, Tijms, Betty M, Bottlaender, Michel, den Braber, Anouk, Brooks, David J, Van Buchem, Mark A, Camus, Vincent, Carill, Jose Manuel, Cerman, Jiri, Chen, Kewei, Chételat, Gaël, Chipi, Elena, Vos, Stephanie J B, Cohen, Ann D, Daniels, Alisha, Delarue, Marion, Didic, Mira, Drzezga, Alexander, Dubois, Bruno, Eckerström, Marie, Ekblad, Laura L, Engelborghs, Sebastiaan, Epelbaum, Stéphane, Ossenkoppele, Rik, Fagan, Anne M, Fan, Yong, Fladby, Tormod, Fleisher, Adam S, Van der Flier, Wiesje M, Förster, Stefan, Fortea, Juan, Frederiksen, Kristian Steen, Freund-Levi, Yvonne, Frings, Lars, Visser, Pieter Jelle, Frisoni, Giovanni B, Fröhlich, Lutz, Gabryelewicz, Tomasz, Gertz, Hermann-Josef, Gill, Kiran Dip, Gkatzima, Olymbia, Gómez-Tortosa, Estrella, Grimmer, Timo, Guedj, Eric, Habeck, Christian G, Group, Amyloid Biomarker Study, Hampel, Harald, Handels, Ron, Hansson, Oskar, Hausner, Lucrezia, Hellwig, Sabine, Heneka, Michael, Herukka, Sanna-Kaisa, Hildebrandt, Helmut, Hodges, John, Hort, Jakub, Aarsland, Dag, Huang, Chin-Chang, Iriondo, Ane Juaristi, Itoh, Yoshiaki, Ivanoiu, Adrian, Jagust, William J, Jessen, Frank, Johannsen, Peter, Johnson, Keith A, Kandimalla, Ramesh, Kapaki, Elisabeth N, Alcolea, Daniel, Kern, Silke, Kilander, Lena, Klimkowicz-Mrowiec, Aleksandra, Klunk, William E, Koglin, Norman, Kornhuber, Johannes, Kramberger, Milica G, Kuo, Hung-Chou, Van Laere, Koen, Landau, Susan M, Altomare, Daniele, Landeau, Brigitte, Lee, Dong Young, de Leon, Mony, Leyton, Cristian E, Lin, Kun-Ju, Lleó, Alberto, Löwenmark, Malin, Madsen, Karine, Maier, Wolfgang, Marcusson, Jan, Clinical sciences, Neuroprotection & Neuromodulation, Neurology, Amsterdam Neuroscience - Brain Imaging, Amsterdam Neuroscience - Neurodegeneration, Radiology and nuclear medicine, Laboratory Medicine, Amsterdam Neuroscience - Neuroinfection & -inflammation, APH - Personalized Medicine, APH - Methodology, RS: MHeNs - R1 - Cognitive Neuropsychiatry and Clinical Neuroscience, and Psychiatrie & Neuropsychologie
- Subjects
Male ,MILD COGNITIVE IMPAIRMENT ,epidemiology [Cognitive Dysfunction] ,positron emission tomography ,Alzheimer`s disease Donders Center for Medical Neuroscience [Radboudumc 1] ,epidemiology [Alzheimer Disease] ,Neuroscience(all) ,diagnostic imaging [Cognitive Dysfunction] ,Amyloidogenic Proteins ,tau Proteins ,cerebrospinal fluid [Amyloid beta-Peptides] ,DIAGNOSIS ,cerebrospinal fluid ,Apolipoproteins E ,Alzheimer Disease ,Prevalence ,Humans ,Amyloid, Alzheimer, PET ,Cognitive Dysfunction ,ddc:610 ,cerebrospinal fluid [Peptide Fragments] ,Aged ,Amyloid beta-Peptides ,neurology ,DEMENTIA ,Correction ,ASSOCIATION ,Amyloidosis ,Middle Aged ,Disorders of movement Donders Center for Medical Neuroscience [Radboudumc 3] ,health care planning ,clinical trial design ,Peptide Fragments ,cerebrospinal fluid [Alzheimer Disease] ,PET ,DRIFT ,Cross-Sectional Studies ,cerebrospinal fluid [Biomarkers] ,cerebrospinal fluid [tau Proteins] ,Radiology Nuclear Medicine and imaging ,Positron-Emission Tomography ,genetics [Apolipoproteins E] ,Female ,Neurology (clinical) ,diagnostic imaging [Alzheimer Disease] ,cerebral amyloid aggregation ,Biomarkers - Abstract
Importance: One characteristic histopathological event in Alzheimer disease (AD) is cerebral amyloid aggregation, which can be detected by biomarkers in cerebrospinal fluid (CSF) and on positron emission tomography (PET) scans. Prevalence estimates of amyloid pathology are important for health care planning and clinical trial design.Objective: To estimate the prevalence of amyloid abnormality in persons with normal cognition, subjective cognitive decline, mild cognitive impairment, or clinical AD dementia and to examine the potential implications of cutoff methods, biomarker modality (CSF or PET), age, sex, APOE genotype, educational level, geographical region, and dementia severity for these estimates.Design, Setting, and Participants: This cross-sectional, individual-participant pooled study included participants from 85 Amyloid Biomarker Study cohorts. Data collection was performed from January 1, 2013, to December 31, 2020. Participants had normal cognition, subjective cognitive decline, mild cognitive impairment, or clinical AD dementia. Normal cognition and subjective cognitive decline were defined by normal scores on cognitive tests, with the presence of cognitive complaints defining subjective cognitive decline. Mild cognitive impairment and clinical AD dementia were diagnosed according to published criteria.Exposures: Alzheimer disease biomarkers detected on PET or in CSF.Main Outcomes and Measures: Amyloid measurements were dichotomized as normal or abnormal using cohort-provided cutoffs for CSF or PET or by visual reading for PET. Adjusted data-driven cutoffs for abnormal amyloid were calculated using gaussian mixture modeling. Prevalence of amyloid abnormality was estimated according to age, sex, cognitive status, biomarker modality, APOE carrier status, educational level, geographical location, and dementia severity using generalized estimating equations.Results: Among the 19 097 participants (mean [SD] age, 69.1 [9.8] years; 10 148 women [53.1%]) included, 10 139 (53.1%) underwent an amyloid PET scan and 8958 (46.9%) had an amyloid CSF measurement. Using cohort-provided cutoffs, amyloid abnormality prevalences were similar to 2015 estimates for individuals without dementia and were similar across PET- and CSF-based estimates (24%; 95% CI, 21%-28%) in participants with normal cognition, 27% (95% CI, 21%-33%) in participants with subjective cognitive decline, and 51% (95% CI, 46%-56%) in participants with mild cognitive impairment, whereas for clinical AD dementia the estimates were higher for PET than CSF (87% vs 79%; mean difference, 8%; 95% CI, 0%-16%; P = .04). Gaussian mixture modeling-based cutoffs for amyloid measures on PET scans were similar to cohort-provided cutoffs and were not adjusted. Adjusted CSF cutoffs resulted in a 10% higher amyloid abnormality prevalence than PET-based estimates in persons with normal cognition (mean difference, 9%; 95% CI, 3%-15%; P = .004), subjective cognitive decline (9%; 95% CI, 3%-15%; P = .005), and mild cognitive impairment (10%; 95% CI, 3%-17%; P = .004), whereas the estimates were comparable in persons with clinical AD dementia (mean difference, 4%; 95% CI, -2% to 9%; P = .18).Conclusions and Relevance: This study found that CSF-based estimates using adjusted data-driven cutoffs were up to 10% higher than PET-based estimates in people without dementia, whereas the results were similar among people with dementia. This finding suggests that preclinical and prodromal AD may be more prevalent than previously estimated, which has important implications for clinical trial recruitment strategies and health care planning policies.
- Published
- 2022
6. Prediction of Response in Head and Neck Tumor: Focus on Main Hot Topics in Research
- Author
-
Belgioia, Liliana, primary, Morbelli, Silvia Daniela, additional, and Corvò, Renzo, additional
- Published
- 2021
- Full Text
- View/download PDF
7. RT-QuIC detection of alpha-synuclein seeds in olfactory mucosa brushings of patients with Dementia with Lewy bodies
- Author
-
Novi, (Novi, G, ( 1 ), G., Perra, Francesco, (Perra, D, ( 2 ), D., Carobbio, ANDREA LUIGI CAMILLO, Alc, (Carobbio, ( 3 ), A. L. C., Schenone, Guido, (Schenone, G, ( 4 ), G., Canevari, FRANK RIKKI MAURITZ, Frm, (Canevari, ( 3 ), F. R. M., Pardini, (Pardini, M, ( 1 ), M., Arnaldi, (Arnaldi, D, ( 1 ), D., Morbelli, SILVIA DANIELA, (Morbelli, Sd, ( 5 ), S. D., Cocchiara, Francesco, (Cocchiara, P, ( 2 ), P., Brozzetti, (Brozzetti, L, ( 2 ), L., Capaldi, (Capaldi, S, ( 2 ), S., Bongianni, (Bongianni, M, ( 2 ), M., Zanusso, (Zanusso, G, ( 2 ), G., Nobili, (Nobili, F, and F. ).
- Published
- 2020
8. Effect of metformin on glucose consumption in normal and in cancer tissue. An in vivo and ex vivo experimental study
- Author
-
Cecilia, Marini, Massollo, Michela, Amaro, ADRIANA AGNESE, Capitanio, Selene, Emionite, Laura, Brignone, Massimo, Cilli, M, Esposito, Alessia, Morbelli, SILVIA DANIELA, Ulrich, Pfeffer, Piana, Michele, and Sambuceti, Gianmario
- Published
- 2012
9. <italic>Mycoplasma hominis</italic> as Cause of Extragenital Infection in Patients with Hypogammaglobulinemia: Report of 2 Cases and Literature Review.
- Author
-
Russo, Chiara, Mikulska, Malgorzata, Delfino, Emanuele, Toscanini, Federica, Mezzogori, Laura, Schiavoni, Riccardo, Bartalucci, Claudia, Angelucci, Emanuele, Bartalucci, Giulia, Gambella, Massimiliano, Raiola, Anna Maria, Morici, Paola, Crea, Francesca, Chiola, Silvia, Morbelli, Silvia Daniela, Marchese, Anna, and Bassetti, Matteo
- Subjects
- *
DIFFUSE large B-cell lymphomas , *LITERATURE reviews , *IMMUNOCOMPROMISED patients , *AGAMMAGLOBULINEMIA , *SPONDYLODISCITIS - Abstract
Mycoplasma hominis can be a part of human urogenital tract microbiome, and it is a frequent cause of urogenital infections. In rare cases, it can also cause extragenital infections, especially in immunocompromised patients. In this case series, we report two cases and provide a literature review of extragenital infections caused byM. hominis in patients with hypogammaglobulinemia. Patient 1 was a 61-year-old woman with diffuse large B-cell lymphoma who, after rituximab-containing chemotherapy and CAR-T therapy, developedM. hominis spondylodiscitis. Patient 2 was a 50-year-old woman with congenital hypogammaglobulinemia who developed disseminatedM. hominis infection involving pleura, muscles, and right ankle. Antibiotic therapy with levofloxacin and doxycycline for 10 weeks in patient 1 and with levofloxacin alone for 6 weeks in patient 2 led to infection resolution. The literature review identified 14 additional cases reportingM. hominis extragenital infection in patients with hypogammaglobulinemia.M. hominis should also be suspected as an etiological agent of extragenital infection in patients with B-cell immunodeficiency with a clinical picture of persistent, standard-culture negative infection, particularly with arthritis or abscess formation. Even ifM. hominis can grow on standard bacterial medium, in suspected cases molecular methods should be promptly used for correct diagnostic work-up and successful therapy. [ABSTRACT FROM AUTHOR]- Published
- 2024
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.